ACOG
$5.76
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tab...
Recent News
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year
This water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands.
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
Euronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets.
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought
This technology firm delivers IT infrastructure and managed solutions to major enterprises across multiple global industries.
Several Insiders Invested In Alpha Cognition Flagging Positive News
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Hedge funds own 20% of Alpha Cognition Inc. (NASDAQ:ACOG) shares but individual investors control 53% of the company
Key Insights Alpha Cognition's significant individual investors ownership suggests that the key decisions are...